Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range
|
|||||
Tiny natural bubbles with infection-receptor proteins found in blood are shown in lab mice to divert and prevent SARS-CoV-2 viruses from infecting real cells. . . . → Read More: Exosomes Shown to Block Broad Covid-19 Variant Range Clinical trial results show an immunotherapy licensed as a lower-priced cancer drug increases survival time in combination with chemotherapy. . . . → Read More: Trial Shows Immunotherapy Improves Lung Cancer Survival Several global issues contribute to the current international trade and manufacturing situation. . . . → Read More: Electric Future of the Global Supply Chain A start-up company is developing a home testing system that combines a saliva test and smartphone app to detect unhealthy stress levels. . . . → Read More: Saliva Test, App for Stress Levels Unveiled A maker of products derived from plants for vaccines and control of crop disease is raising $6.1 million in its first venture funding round. . . . → Read More: Plant Science Products Company Raises $6.1M in Early Funds Venture funding worldwide rose sharply in 2021, with investment dollars climbing to nearly $621 billion, more than twice the total invested in 2020. . . . → Read More: Infographic – Venture Funds More Than Double in 2021 Advances in genetics are providing communities, businesses, and homeowners with new tools for controlling harmful insects. . . . → Read More: Genetics Help Control Dangerous Insects A clinical trial is underway testing an implanted device providing electronic stimulation along with spinal fusion surgery to treat chronic lower back pain. . . . → Read More: Spinal Fusion/Stimulation Trial for Back Pain Underway Idaho National Laboratory chose an energy software company to design a technology platform for local distribution of non-carbon electrical power. . . . → Read More: National Lab, Software Company Partner on Net-Zero Microgrid Results of a clinical trial show a microbial supplement in the gut reduces respiratory symptoms and viral load in people with mild Covid-19 disease. . . . → Read More: Trial Shows Gut Probiotic Reduces Covid-19 Disease |
|||||
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |